Based on recent data, Medline Inc. (MDLN) shows an Average True Range (ATR) of 2.14 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 9.69M, indicating liquidity. These fundamental metrics provide insight into MDLN's underlying financial health and market activity.
| ATR | 2.14 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 9.69M |
| Avg Vol (10 Days) | 5.54M |
Medline Inc. (MDLN) technical indicators as of July 29, 2026: the SMA 20 is 5.03%, SMA 50 at 10.41%, and SMA 200 at 10.41%. The RSI 14 value is 61.05, suggesting its current momentum. These technical analysis signals help assess MDLN's price trends and potential future movements.
| SMA 20 | 5.03% |
| SMA 50 | 10.41% |
| SMA 200 | 10.41% |
| RSI 14 | 61.05 |
Medline Inc. (MDLN) stock performance overview as of July 29, 2026: The 52-week high is N/A (currently -3.9% below), and the 52-week low is N/A (currently 40.13% above). Over the past year, MDLN's performance is N/A, compared to the S&P 500's 3.36% change.
| 52-Week High | N/A |
| 52-Week High Chg | -3.90% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +40.13% |
| S&P 500 52-Week Chg | 3.36% |
According to current financial data, MDLN stock's P/E (TTM) ratio is 33.39, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for MDLN, including P/S (1.17), P/B (2.94), and P/FCF (22.40), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | MDLN | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 33.39 | -1.24 | 6.99 | 32.59 |
| P/S (TTM) | 1.17 | 3.7 | 14.69 | 5.98 |
| P/B (TTM) | 2.94 | -0.71 | 3.94 | 5.59 |
| P/FCF (TTM) | 22.4 | -3.39 | 48.53 | 31.65 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep